Tissiumis a mission-driven medical device companyfounded in 2013, headquartered in Paris, with a production facility in Roncq(near Lille) and an office in Boston We are dedicated to creating a new era of body repairby leveraging our biopolymer platformto develop innovative solutions in surgeryfor a positive impact on patients' lives
Tissium’s technologyis based on research and intellectual propertyfrom the laboratories of Professor Robert Langer (MIT)and Professor Jeffrey M. Karp (Brigham and Women's Hospital), who co-founded the company with Christophe Bancel (CEO)and Maria Pereira (Deputy CEO & Chief Innovation Officer)
We are developing polymers for atraumatic tissue repairin various applications. Today, these polymersare used for sutureless nerve repair, hernia repair, and cardiovascular sealing
Since our inception, we have raised a total of 170 million euros Our latest fundraising round, which concluded in April 2023, resulted in 50 million euros in additional funding This infusion of capital provides us with the necessary resources to finance the commercialization of our first products
TISSIUM is moving from a phase of GenAI experimentation to a more fundamental transformation: embedding automation and AI into how the company operates. This role owns both the strategy and the execution – identifying where digital creates value, building the solutions, driving adoption, and progressively enabling teams to operate with digital tools.
Maintain and evolve existing automations and digital tools – ensure continuity, uptime, and adoption of solutions already in place.
Identify and assess opportunities for leveraging digital cross-functionally – proactively engage stakeholders across R&D, Quality, Regulatory, Manufacturing, and Corporate functions to surface high-impact use cases, build business cases, and prioritise by workload vs. value.
Build automations, integrations, and internal tools that remove manual, fragile, or repetitive work. Develop connectors between data, documents, and systems.
Deliver MVPs (AI-powered tools, workflows, services) used daily by R&D, Quality, Regulatory, and Manufacturing teams. Use GenAI when it helps, deterministic automation when it’s better, and humans where accountability matters.
Drive company-wide GenAI adoption – train and coach teams to use AI tools, embed a technology-first reflex in daily work, and progressively build internal autonomy.
Work directly with scientists and operators in an environment full of unknowns and real constraints – including regulated (GxP) and manufacturing contexts.
Shape the longer-term digital vision – define the roadmap for increased automation, optimisation of digital resources, and advanced initiatives such as programmable polymer behavior simulation.
This posiiton will report to the VP, Portfolio Strategy.
Proven ability to work directly with non-technical stakeholders – explain, train, and drive adoption.
Strong stakeholder management across R&D, Operations, and business teams.
Clear, structured communication; fluent English.
Enjoys ambiguity, ownership, and shipping real things.
Strong hands-on engineer (Python required).
Experience building automations, APIs, integrations, and MVPs used by real teams.
Comfortable with cloud environments (AWS or GCP).
Practical experience with LLMs / GenAI (RAG, fine-tuning, prompt engineering).
Act with a sense of urgency Align stakeholders around critical milestones and drive timely execution.
Embrace calculated risk-taking Take thoughtful risks that create cross-functional impact.
Continuously learn and share Demonstrate a strong learning mindset, share knowledge, and support team development.
Challenge the status quo Question existing practices to improve systems, processes, and outcomes.
Balance tactical and strategic thinking Combine operational excellence with a clear mid-term vision.
Assume positive intent Foster constructive and respectful collaboration across teams.
Drive active collaboration Coordinate multiple stakeholders toward shared objectives.
Own outcomes Take responsibility for project results and deliverables.
Strive for excellence Lead high-impact improvements in quality and performance.
A dynamic and stimulating environment, with a culture focused on initiative, learning, and continuous improvement.
Real opportunities for growth and development, with evolving career paths and tailored training.
The chance to join an ambitious startup at the forefront of high-impact medical innovation.
A strong commitment to ESG, embedded in our strategy from day one.
Attractive conditions: work-life balance, competitive package, and internal mobility (Paris, Roncq, Boston).
An international and diverse environment, with more than 19 nationalities represented.
HR Interview (30 minutes)
Hiring Manager Interview (1 hour)
Technical Assessment or Case Study
Final On-site Interview ( 2 hours)
In some cases, we may also request professional references(including contact details).
Intrigued? We’d love to hear from you! Apply today - we’re standing by for your resume!
👉 We believe that building an inclusive company starts with a diverse team. We value diversity and encourage applications from people of all backgrounds. We are committed to equal opportunity and do not tolerate discrimination of any kind, including on the basis of gender, gender identity or expression, sexual orientation, origin, family situation, age, beliefs, disability, health status, or any other characteristic protected by law.
Our recruitment process is designed to be simple, transparent, and conversation-driven. We prioritize human interaction and ensure that every application is reviewed carefully and fairly.
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.
Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.
Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.
We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.
